Dr. Marcus will be in Stuart Florida to talk about Surface and Sub-surface reconstruction of the damaged joint.
April 5, Waterview Conference Center
Topic: Juvenile Allograft for Cartilage Reconstruction
Dr. Marcus is to speak on the role of PRP and Cartilage Repair at the forthcoming Sanibel Perfusion Symposium, Ft. Myers Fla.
Feb 15, 2014.
Dr. Marcus was elected as a Senior Fellow and Honorary member of the ICRS (International Cartilage Repair Society) in recognition of his contributions
to the field and for being a thought leader in cartilage repair.
May 2, Tyler Texas
May 16, Shreveport, Louisiana
May 23 Las Vegas Nevada
June 13, Des Moines, Iowa
June 20, Minneapolis, Minnesota
Developments by Dr. Eric Giza (Sacramento, CA) and Dr. Andrew Wolff (Arlington, VA) are pushing the technology of Denovo NT insertion into the realm of arthroscopy. It is possible to insert the particles of Denovo NT through a tube (cannula)and to glue them in position in either the hip or the ankle joint. Now with over 6000 implants in patients, these improvements will no doubt further the use of this implant.
I recently returned from the America Academy of Orthopedic Surgery (AAOS) meeting in Chicago and am pleased to report a tide of interest in cartilage repair and stem cells. There are several new cartilage repair products on the market or soon coming, and the interest of industry is keen, in fact, greater than I have ever seen it before. Also noted was the presence of FDA representatives at the exhibits, who were apparently checking on “claims” for stem cell preparations and various “off-label” indications of bone marrow aspirate (BMA). It is good that they should do this, because as has been stated before in this column (and also by the ISSCR (http://www.isscr.org/) stem cell organization) false and premature claims of efficacy are often used to mislead the public. Not a week goes by that I am not asked by some patient to put “stem cells” in their knee. Never mind that the number of stem cells in BMA is quite low, the public is vulnerable to unproven technologies and indeed part of the vulnerability- some would say gullibility- is generated not by industry but by the public themselves. And of course some physicians willingly cooperate, for a large fee.
IMO, if we are going to promote stem cell therapy (for anything) first we must count and measure and prove that we have stem cells to begin with. Lets start with that. (http://www.clinicaltrials.gov/ct2/show/NCT01273337?term=stroke&rank=112) Then, we can do some studies and perhaps learn something.
Thurs 3/28/13 Fayetteville Arkansas
Fri April 5, 2012 at the Cherry Blossom Orthopedic Meeting
Thurs April 11, 2013 Mahwah New Jersey
Thrs May 2, 2013 Tyler Texas
Thurs, May 9, 2013 Baton Rouge Lousiana
Thurs May 23, 2013 Las Vegas Nevada
Weds, June 5, 2013 Wilmington North Carolina
Thurs June 13, Des Moines Iowa
Thurs June 20, Minneapolis Minnesita
Weds June 26, 2012 Gibbsboro Pennsylvania
The Virginia Cartilage Institute will soon be offering platelet rich plasma injections for the hip. This is now possible due to new ultrasound equipment that allows proper visualization of the hip joint. There are currently (3) well documented studies of PRP published in the peer-reviewed medical literature showing impressive efficacy for osteoarthritis in those patients with mild to moderate disease. those patients with severe disease and stiffness are most likely better served by arthroplasty.
March 7, Charlotte NC
March 14, Durham NC
March 20 Chicago Ill at the AAOS meeting
April 11 Mahwah NJ
April 13, San Francisco CA
May 2, Tyler Texas
May 23, Las Vegas, Nevada